They may expand the relationship in the US as well and offer a global partnership for research/clinical trial market. That would be the classic partnership with an upfront and likely sales milestones. In the next 12-18 months AMBS would likely get many BP's interested in laying down a bid but a large Diagnostic company like Quest or the like would pay top dollar to buy Lympro at that point.